
Loading, please wait...

Loading, please wait...

Lesser sphenoid wing dAVF (dural arteriovenous fistulas) are rare neurovascular lesions that require precise terminology to guide treatment. These complex fistulas primarily receive blood from the middle meningeal and ophthalmic arteries. Consequently, clinicians must understand the unique angioarchitecture of the sphenoparietal sinus to ensure clinical success and patient safety.
A recent review of cases highlights that microsurgery offers a more definitive cure than endovascular therapy. Specifically, surgeons achieved complete obliteration in 100% of microsurgical cases in the authors' series. In contrast, endovascular procedures faced a failure rate of nearly 67%. This high failure rate occurs because the anatomical features of these fistulas often prevent complete occlusion through a catheter. Furthermore, navigating the ophthalmic artery carries significant risks that specialists can avoid with open surgery.
Therefore, microsurgical management remains the preferred option for Borden type III fistulas in this region. Moreover, the bridging vein originating from the lesser wing typically serves as the primary drainage route. By using a direct surgical approach, specialists can ensure low morbidity and high success rates for their patients.
Microsurgical clip ligation is currently considered the most effective treatment. It provides direct access to the fistula and achieves a 100% occlusion rate in reported clinical series, significantly outperforming endovascular options.
Endovascular therapy often fails due to the complex angioarchitecture and the risks associated with navigating the ophthalmic artery. The anatomical structure of the sphenoparietal sinus frequently results in incomplete occlusion when using endovascular techniques.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Serioli S et al. Rethinking the sphenoparietal sinus: implications for lesser sphenoid wing dural arteriovenous fistulas. Illustrative cases. J Neurosurg Case Lessons. 2026 May 18. doi: undefined. PMID: 42150199.
Fukuda H, et al. Endovascular treatment of sphenoid wing dural arteriovenous fistula with pure cortical venous drainage. J Stroke Cerebrovasc Dis. 2014;23(8):1730-1735.
Kandyba DV, et al. Dural arteriovenous fistula in the sphenoid bone lesser wing region: Endovascular adjuvant techniques and literature review. Interv Neuroradiol. 2018;24(5):559-566.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study evaluates management for rare lesser sphenoid wing dAVFs, finding microsurgery superior to endovascular therapy for achieving complete obliteration....
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today